Does Novo Nordisk A/S (NVO) have a biopharmaceutical segment?

Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders. Find the latest Novo Nordisk A/S (NVO) stock quote, history, news and other vital information to help you with your stock trading and investing.

How do I see my recent viewed NVO tickers?

Log in to see them here or sign up to get started. Visit a quote page and your recently viewed tickers will be displayed here. NVO | A complete NVO overview by MarketWatch. View the latest market news and prices, and trading information.

Does Novo Nordisk stock look expensive today?

Novo Nordisk's stock may look expensive today, but that may not be the case in even a year or two. The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies. Back then, the company wasn't very well known to U.S. investors. That's absolutely not the case these days.